57 reports

  • Genetic diseases
  • Non-genetic diseases

The following are the commonly occurring monogenic disorders: Common types of genetic disorders Genetic diseases Global prenatal DNA sequencing market by genetic diseases - Market size and forecast 2017-2022 ($ mn) Down syndrome is one o

  • Genome Sequencing
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Natera, Inc.

MARKET OVERVIEW Genotyping - A Prelude Increasing Incidence of Genetic Diseases Propels the Genotyping Assays Market Which Genotyping Techniques Can be Adopted???

  • Biotechnology
  • Genome Sequencing
  • Genomics Proteomics And Enabling Technology
  • World
  • Market Shares
  • 5.1 GLOBAL NEXT GENERATION SEQUENCING (NGS) - SAMPLE PREPARATION
  • AND FORECAST

Mendelian disorders (rare genetic disorders) are difficult to diagnose.

  • Genome Sequencing
  • World
  • Forecast
  • Illumina, Inc.
  • Oxford Nanopore Technologies Limited
  • UK Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Global Whole Exome Sequencing Market, By Geography (US$ Mn)

According to the Genetic Disorders UK, it is estimated that in the UK, nearly one in twenty-five children are diagnosed with a genetic disorder.

  • Genome Sequencing
  • World
  • Forecast
  • Market Size
  • Thermo Fisher Scientific, Inc.

The results will be available within one to three days.

  • DNA
  • Genome Sequencing
  • Genomics
  • Genomics Proteomics And Enabling Technology
  • World
  • SNP GENOTYPING MARKET
  • SNP GENOTYPING MARKET

THE NUMBER OF GENETIC TESTS AND DIAGNOSES FOR GENETIC DISEASES IS INCREASING EVERY YEAR IN JAPAN.

  • Genome Sequencing
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • Luminex Corporation
  • 4. GLOBAL EPIGENETICS MARKET - KEY MARKET DYNAMICS

NGS helps in biomarker discovery for identification of genetic diseases.

  • Genome Sequencing
  • World
  • Forecast
  • Market Size
  • Illumina, Inc.

Figure ##. ##.

  • Genome Sequencing
  • World
  • Forecast
  • Market Size
  • Bruker Corporation

Microbiome sequencing is one key process used in analysis of human microbiomes.

  • Biotechnology
  • Genome Sequencing
  • Genomics Proteomics And Enabling Technology
  • World
  • Forecast
  • 8.4.1 OVERVIEW

NGS helps in biomarker discovery for identification of genetic diseases.

  • Genome Sequencing
  • APAC
  • World
  • Forecast
  • Market Size
  • U.A.E NEXT GENERATION SEQUENCING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

NGS helps in biomarker discovery for identification of genetic diseases.

  • Genome Sequencing
  • World
  • Forecast
  • Market Size
  • Illumina, Inc.
  • PART 1. INTRODUCTION

NGS enables in discovery of biomarker and identifying the genetic diseases.

  • Genome Sequencing
  • Europe
  • World
  • Forecast
  • Market Size

NGS helps in biomarker discovery for identification of genetic diseases.

  • Genome Sequencing
  • North America
  • Forecast
  • Market Size
  • Agilent Technologies, Inc.
  • Global Next Generation Sequencing Services Market in Genome Sequencing, 2015 -
  • Assessment by Applications, Forecast: 2017 to 2021

Current research is aimed at identifying key genetic disease markers.

  • Genome Sequencing
  • Genomics Proteomics And Enabling Technology
  • World
  • Illumina, Inc.
  • Oxford Nanopore Technologies Limited
  • Market segments

Hence, a patient may have to undergo several genetic tests before the disease-causing mutation is identified.

  • Genome Sequencing
  • World
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • 5 NEXT GENERATION SEQUENCING MARKET VALUE AND VOLUME ANALYSIS, BY TECHNOLOGY
  • The recent developments of Strand Life Sciences Pvt. Ltd. are listed in the below table

Cancer is one of the complex diseases as it has environmental, genetic and lifestyle factors contributing to it.

  • Genome Sequencing
  • World
  • Market Size
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • 11 NEXT GENERATION SEQUENCING GLOBAL MARKET

It is best suited for screening one genetic marker or protein across thousands of samples.

  • Genome Sequencing
  • Market Size
  • Agilent Technologies, Inc.
  • Bruker Corporation
  • Illumina, Inc.
  • OTHER COUNTRIES IN ROW: AGRIGENOMICS MARKET SIZE, BY OBJECTIVE, 2014-2021 (USD MILLION)
  • SAUDI ARABIA: AGRIGENOMICS MARKET SIZE, BY OBJECTIVE, 2014-2021 (USD MILLION)

Scientists identify the mutant genotypes responsible for an inherited genetic disorder through genetic disease identification tests.

  • Genome Sequencing
  • United States
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • OTHER COUNTRIES IN ROW: AGRIGENOMICS MARKET SIZE, BY OBJECTIVE, 2014-2021 (USD MILLION)
  • SAUDI ARABIA: AGRIGENOMICS MARKET SIZE, BY OBJECTIVE, 2014-2021 (USD MILLION)

Scientists identify the mutant genotypes responsible for an inherited genetic disorder through genetic disease identification tests.

  • Genome Sequencing
  • United States
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.

ONE OF THE LEADING MOLECULAR DIAGNOSTICS COMPANY DEVELOPS AND MARKETS PRODUCTS TO IMPROVE GENETIC TESTING.

  • Genome Sequencing
  • World
  • Market Size
  • CareDx, Inc.
  • Illumina, Inc.

THE JV IS EXPECTED TO DEVELOP AND COMMERCIALIZE MOLECULAR DIAGNOSTIC ASSAYS FOR THE CHINESE MARKETS IN ONCOLOGY, INFECTIOUS DISEASE TESTING, AND GENETIC DISEASE TESTING.

  • Biotech Diagnostics
  • Genome Sequencing
  • China
  • Amoy Diagnostics CO., LTD.
  • CapitalBio Corporation
  • GLOBAL DNA SEQUENCING MARKET POTENTIAL BY USES (2014)
  • EXECUTIVE SUMMARY

The genes can provide valuable information about genetic conditions and mutations that may cause disease.

  • Genome Sequencing
  • World
  • Illumina, Inc.
  • Life Technologies Corporation
  • Roche Group

DNA Sequencing Markets: Global Analysis and Opportunity Evaluation 2016 - 2020 ##.

  • Biotechnology
  • Genome Sequencing
  • Genomics
  • Genomics Proteomics And Enabling Technology
  • 11.1 INTRODUCTION
  • GEOGRAPHICAL SNAPSHOT OF THE CARRIER SCREENING MARKET

GENETIC DISEASES FORM ONE OF THE LEADING CAUSES OF INFANT DEATH ACROSS THE WORLD.

  • Genome Sequencing
  • Molecular Diagnostics
  • North America
  • United States
  • Invitae Corporation
  • Thermo Fisher Scientific, Inc.'s Sequencing Product Overview
  • North America Sequencing Market

THE GENOME SEQUENCING PROJECT WILL HELP TO DIAGNOSE BIRTH DEFECTS AND GENETIC DISORDERS IN NEWBORNS.

  • Genome Sequencing
  • Genomics Proteomics And Enabling Technology
  • World
  • Forecast
  • Illumina, Inc.

Five-year sales forecasts for the German Molecular Diagnostics market, including: - Infectious Diseases - Cancer - Forensic Testing - Genetic Diseases - Paternity Testing/ HLA Typing, and other applications. ?

  • DNA
  • Genome Sequencing
  • Germany
  • Demand
  • Forecast

" I am excited to join CENTOGENE, one of the world' s leading companies in rare diseases.

  • Diagnostics
  • Genome Sequencing
  • Pharmaceutical
  • Germany
  • Centogene AG
  • COLLABORATION QIAGEN

THESE TESTS CAN ACCESS MULTIPLE GENES IN PARALLEL FOR TESTING VARIOUS GENETIC DISORDERS, AND CAN BE PERFORMED ON INDIVIDUALS SHOWING NO DISEASE PHENOTYPE BUT HAVE A FAMILY HISTORY OF GENETIC DISEASE.

  • Cancer
  • Genome Sequencing
  • North America
  • United States
  • Thermo Fisher Scientific, Inc.
  • GENOTYPING MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
  • MEDIUM

THE INCIDENCE OF GENETIC DISEASES HAS ALSO INCREASED IN RECENT YEARS.

  • Genome Sequencing
  • Genomics Proteomics And Enabling Technology
  • Forecast
  • Market Size
  • Thermo Fisher Scientific, Inc.
  • ILLUMINA INC PIPELINE PRODUCTS AND ONGOING CLINICAL TRIALS OVERVIEW

## Down' s Syndrome ## Edwards Syndrome ## Genetic Disorder ## Graft Versus Host Disease ## Human Immunodeficiency Virus Infection ## Hyperbilirubinemia ## Jaundice ## Lysosomal Storage Disorders

  • Clinical Trial
  • Genome Sequencing
  • Medical Biotechnology
  • Molecular Diagnostics
  • Illumina, Inc.